A recent study reveals that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional diet and exercise regimens.
Published data in a leading medical journal demonstrates that while overweight people often shed substantial amounts of their body weight while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals using such medications need to be cognizant of the potential of rapid rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to original mass within about 18 months.
Analyzing Therapies
The study, which looked at 37 of studies involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills.
Researchers emphasize that individuals who lose weight through lifestyle changes alone typically have a slower creep back—around 100 grams monthly—after stopping.
Explaining the Quick Rebound
Doctors suggest the way of the jabs accounts for the accelerated regain.
These medications copy a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating a significant risk."
A Lifelong Disease?
The NHS suggest the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Many experts contend that, given the likelihood of weight regain, the treatment might need to be life-long.
This perspective is echoed by drug manufacturers, who state that the findings "underscore the chronic nature of obesity," similar to managing conditions like high blood pressure.
Patient Experiences
Individuals who have come off the jabs report a powerful resurgence of appetite.
"I experienced something flipping and you become extremely hungry," said one woman.
This challenge is compounded if patients have not established permanent lifestyle or habit modifications during therapy.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while these medications are powerful agents for weight loss, they are not a permanent fix and long-term success relies on ongoing lifestyle support.
